Premium Nahrungsergänzungsmittel | artgerecht

Felty Syndrome: Causes, Symptoms & Treatment

Felty syndrome is a rare complication of rheumatoid arthritis characterized by an enlarged spleen and low neutrophil count, significantly increasing the risk of infections.

Regular tips about health Regular tips about health

Things worth knowing about "Felty syndrome"

Felty syndrome is a rare complication of rheumatoid arthritis characterized by an enlarged spleen and low neutrophil count, significantly increasing the risk of infections.

What is Felty Syndrome?

Felty syndrome is a rare and severe variant of rheumatoid arthritis (RA). It is defined by a classic triad of three key features: rheumatoid arthritis, an enlarged spleen (splenomegaly), and a reduced number of neutrophils in the blood (neutropenia). The condition affects fewer than 1% of patients with rheumatoid arthritis and is more common in women than men, typically presenting in middle to older age. It was first described in 1924 by the American physician Augustus Roi Felty.

Causes and Risk Factors

The exact causes of Felty syndrome are not yet fully understood. It is believed that an autoimmune reaction plays a central role, in which the immune system mistakenly attacks the body's own neutrophils in the blood and bone marrow.

Long-standing, severe rheumatoid arthritis (usually present for more than 10 years)
High levels of rheumatoid factor in the blood
Specific genetic markers, particularly the HLA-DR4 antigen
Female sex and older age
Rheumatoid nodules and other extra-articular manifestations of RA

Symptoms

The symptoms of Felty syndrome are diverse and reflect both the underlying rheumatoid arthritis and the consequences of neutropenia:

Joint pain and swelling typical of rheumatoid arthritis
Enlarged spleen (splenomegaly), sometimes felt as pressure or fullness in the upper left abdomen
Frequent and severe infections, especially bacterial infections of the respiratory tract and skin, due to the lack of neutrophils
Enlarged lymph nodes (lymphadenopathy)
General fatigue, weight loss, and fever
Skin changes such as brown pigmentation on the legs
Occasionally an enlarged liver (hepatomegaly)

Diagnosis

The diagnosis of Felty syndrome is based on identifying the characteristic triad along with laboratory tests and imaging:

Complete blood count: Demonstrating neutropenia (neutrophils below 1,800 cells per microliter of blood)
Rheumatoid factor and anti-CCP antibodies: Usually significantly elevated
Abdominal ultrasound or CT scan: To assess the size of the spleen and liver
Bone marrow biopsy: In unclear cases to evaluate blood cell production
Exclusion of other causes of neutropenia and splenomegaly (e.g., infections, other hematological disorders)

Treatment

Treatment of Felty syndrome aims to control the underlying rheumatoid arthritis and improve neutrophil counts in order to reduce the risk of infection.

Medical Therapy

Methotrexate (MTX): Considered the first-line treatment and can significantly improve neutrophil counts
Biologics: Particularly TNF-alpha inhibitors (e.g., etanercept, infliximab) show good efficacy in controlling RA and neutropenia
G-CSF (granulocyte colony-stimulating factor): May be used in severe neutropenia to temporarily increase neutrophil counts
Corticosteroids for short-term anti-inflammatory management

Surgical Therapy

In severe cases with marked splenomegaly and treatment-resistant neutropenia, surgical removal of the spleen (splenectomy) may be considered. This can durably improve neutrophil counts, though it does not address the underlying autoimmune disease.

Infection Management

Due to the increased susceptibility to infection, regular vaccinations (e.g., against pneumococcus and influenza) and prompt treatment of infections are especially important for patients with Felty syndrome.

Prognosis

The prognosis of Felty syndrome is variable. With modern immunosuppressive therapy, particularly methotrexate and biologics, the condition can be well managed in many patients. The greatest risk lies in recurrent severe infections, which can be life-threatening without consistent treatment. Regular medical follow-up is essential.

References

Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia associated with Felty syndrome. Leukemia and Lymphoma. 1996;23(3-4):261-266. PubMed PMID: 9031105.
Doran MF, Crowson CS, Pond GR, et al. Predictors of infection in rheumatoid arthritis. Arthritis & Rheumatism. 2002;46(9):2294-2300.
Firestein GS, Budd RC, Gabriel SE, et al. Kelley & Firestein's Textbook of Rheumatology, 10th ed. Elsevier, 2017.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.